Connect with us

Business

Why the Alterity (ASX:ATH) share price is skyrocketing 42% today

Published

on

ADVERTISEMENT

One of the best performers on the ASX today is the Alterity Therapeutics Ltd (ASX: ATH) share price. Driving the meteoric rise, the biotech company announced positive results for its lead compound, ATH434.

At the time of writing, Alterity shares are swapping hands for 4.25 cents apiece, up 41.67%.

What does Alterity do?

Alterity is an Australian biotech company that focuses to commercialise research into neurodegenerative disorders. This includes Parkinsonian movement disorders, Alzheimer’s disease, Huntington disease and others.

The company’s lead candidate ATH434 is currently in development. It aims to block the aggregation of pathological proteins that cause brain degeneration. Current remedies include medications and…



Click here to view the original article.

Continue Reading
Advertisement

You might also like ...

Up 5%, Treasury Wine (ASX:TWE) share price continues its climb
What resurgent inflation really means for your ASX shares